DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Steenholdt C, Svenson M, Bendtzen K. et al.
Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease.
Aliment Pharmacol Ther 2011;
34: 51-58
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.